Pessac, France

Claude Feniou


Average Co-Inventor Count = 4.7

ph-index = 3

Forward Citations = 51(Granted Patents)


Company Filing History:


Years Active: 1978-1989

Loading Chart...
19 patents (USPTO):Explore Patents

Title: Claude Feniou: A Pioneer in Pharmaceutical Innovations

Introduction

Claude Feniou, located in Pessac, France, is a renowned inventor with a remarkable portfolio comprising 19 patents. His contributions to the field of pharmaceuticals are significant, particularly in the development of various compounds with therapeutic applications.

Latest Patents

Among Claude Feniou's latest patents are innovative methods related to pharmaceutical compounds. One notable patent focuses on derivatives of 4-aminoethoxy-5-isopropyl-2-methylbenzenes, which exhibit alpha 1-blocking activity. The formula for this compound includes specific substitutions that enhance its biological activity. Another significant patent details a novel method for preparing D-ribose, which involves a series of chemical transformations starting from a 1,5-di-O-alkyl derivative of D-xylofuranose. This method highlights his expertise in carbohydrate chemistry and showcases a sophisticated approach to synthesizing vital sugars.

Career Highlights

Throughout his career, Claude Feniou has made impactful contributions while working with notable companies such as Societe Cortial and Laboratoires Sarget. His extensive experience in the pharmaceutical industry has enabled him to hone his skills in invention and innovation, paving the way for significant advancements in drug development.

Collaborations

Collaboration has been a crucial aspect of Claude's career. He has notably worked alongside esteemed peers, including Gisele Prat and Henri Pontagnier. Their combined expertise has likely fostered a rich environment for innovative research and development within the pharmaceutical sector.

Conclusion

Claude Feniou's dedication to innovation in pharmaceuticals is evident through his numerous patents and collaborations. His work continues to influence the field, ensuring that new therapeutic options are developed for the benefit of healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…